Lawrence Daniel Mullany, MD MBA FACP | |
12272 Declaration Ave, Chester, VA 23836-3057 | |
(941) 779-3793 | |
Not Available |
Full Name | Lawrence Daniel Mullany |
---|---|
Gender | Male |
Speciality | Internal Medicine - Infectious Disease |
Location | 12272 Declaration Ave, Chester, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841749272 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 0101257022 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lawrence Daniel Mullany, MD MBA FACP 12272 Declaration Ave, Chester, VA 23836-3057 Ph: (941) 779-3793 | Lawrence Daniel Mullany, MD MBA FACP 12272 Declaration Ave, Chester, VA 23836-3057 Ph: (941) 779-3793 |
News Archive
People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing an allergic reaction to the very treatment that can prolong their lives.
Healthline Networks, the leading provider of intelligent health information services, and MedHelp, the world's largest health social network and the leading provider of online and mobile health applications, today announced an expansion of their strategic partnership, naming Healthline as the exclusive third-party representative for custom content programs for selected pharmaceutical advertisers on MedHelp.
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today first dosing of subjects in a Phase 1 clinical trial of TCN-202, a broadly protective, fully human monoclonal antibody in development for the treatment of human cytomegalovirus (CMV) infection.
Cumberland Pharmaceuticals Inc. today announced that results from a patient preference study evaluating Kristalose (lactulose) for Oral Solution, a prescription laxative packaged as a crystalline powder, will be presented at the 2010 Digestive Disease Week meeting in New Orleans.
Researchers have analyzed this evolution of the virus based on evolutionary ecology theory. Using the virus genomes available in the Global Initiative on Sharing Avian Influenza Data (GISAID) database, the researchers focused their inquiry on mutations in the receptor-binding domain (RBD) on the spike protein of SARS-CoV-2.
› Verified 7 days ago
Dr. Yinan Chou, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 12600 Iron Bridge Rd, Chester, VA 23831 Phone: 804-796-2371 Fax: 804-796-2371 | |
Gohar M Abbasi, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1714 E Hundred Rd, Suite 101, Chester, VA 23836 Phone: 804-530-5293 Fax: 804-530-5295 | |
Mohammad Farooq, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1714 E Hundred Rd Ste 101, Chester, VA 23836 Phone: 804-590-6750 | |
Dr. Sujatha P Vuyyuru, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 110 Old Bermuda Hundred Rd, Chester, VA 23836 Phone: 804-530-9966 | |
Dr. Edward Kwodwo Boakye, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 12407 Inverness Way, Chester, VA 23836 Phone: 703-768-9660 | |
Gregory K Lemite, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1714 E Hundred Rd, Ste 104, Chester, VA 23836 Phone: 804-681-0556 Fax: 804-410-4619 | |
Clifford Vincent Morris, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 228 Johnson Creek Drive, Chester, VA 23836 Phone: 804-530-1044 Fax: 877-718-0972 |